The European Investment Bank (EIB), the long-term financing arm of the European Union, has begun rolling out a new borrowing facility for research-intensive companies which might otherwise be unable to obtain capital.
The Bioprocessing Research Industry Club (BRIC) has awarded £3.5 million to researchers at seven UK universities for projects that will make the manufacture of biopharmaceuticals more efficient.
Pronova BioPharma ASA, which has a patented method of extracting and concentrating omega-3 ethyl esters from fish oil, is having its shares listed on the Oslo Stock Exchange in an initial public offering (IPO) of 105,915,432 shares at a price of between NOK 23 and NOK 29 per share.
Stem Cell Sciences Plc said it is coordinator of a new collaboration that will design bioassays that can be used to discover new candidates for treating cancer, Alzheimer’s disease, stroke and epilepsy.
GATC Biotech AG, a German DNA sequencing service provider, said it has signed a collaboration agreement with three partners to develop a DNA microarray-based diagnostic test able to detect both bacterial and fungal sepsis-triggering pathogens
The chairman of Allergy Therapeutics Plc said he expects the FDA hold on its clinical trials of Pollinex Quattro to be lifted in due course.
Omega Pharma NV is spinning out its professional health division, Arseus NV., with an Initial Public Offering (IPO) of 23.5 million shares on the Euronext in Brussels and Amsterdam.
A committee of the European Medicine Agency has recommended that six drugs, including one generic medicine, be authorised for marketing in the European Union.
The UK Medical Research Council (MRC) said that it will fund a research project from the North East England Stem Cell Institute that involves partially financing in vitro fertilisation (IVF) treatments for women who donate their surplus eggs for stem-cell research.
Researchers at University College London and Novozymes Delta UK Ltd are working together to develop potential therapeutics for cancer.